MEDIPAL HOLDINGS CORPORATION announced that it would conduct a share buyback of up to ¥10 billion and 4 million shares, aiming to strengthen shareholder returns and improve capital efficiency. It also raised its net income forecast for the fiscal year ending March 2027 to ¥53 billion.
MEDIPAL Holdings will conduct a share buyback covering shares equivalent to 2% of the total number of shares issued, excluding treasury shares, with a cap of 4 million shares. The acquired shares will be cancelled, and the buyback is scheduled to be completed by 31 March 2027.
The share buyback is intended to strengthen shareholder returns and improve capital efficiency.
On the same day, the company revised its earnings forecast for the fiscal year ending March 2027 upward, raising consolidated net income by ¥10 billion from the previous forecast to ¥53 billion, an increase of 25% from the previous fiscal year. The forecasts for revenue and operating profit were left unchanged.